The Trump administration has approved eight drugmakers’ rebate plans for a controversial 340B drug discount pilot program that kicks off January 1.
Related Posts
What real-world data will regulators consider in Europe? – Healthcare Economist
A 2024 Data Quality Framework (DQF) from the European Medicines Agency (EMA) aims to provide some guidance for drug manufacturers. Here is a summary of […]
X-ray TM Joints LAT
What is an X-ray TM Joints LAT? When obtaining LAT (lateral) views of the patient, the X-ray beam is positioned anteriorly and laterally to the […]
I’m Sensing Some Future – The Health Care Blog
By KIM BELLARD One of my frequent laments is that here we are, a quarter of the way into the 21st century, yet too much […]